Merit Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,004
Closed -$135K – 2527
2026
Q2
$135K Buy
+10,004
New +$120K ﹤0.01% 2187
2026
Q1
– Sell
-16,409
Closed -$118K – 2176
2025
Q4
$118K Sell
16,409
-16,416
-50% -$130K ﹤0.01% 1882
2025
Q3
$351K Buy
32,825
+10,247
+45% +$101K ﹤0.01% 1353
2025
Q2
$219K Buy
22,578
+8,835
+64% +$91.1K ﹤0.01% 1507
2025
Q1
$205K Buy
+13,743
New +$211K ﹤0.01% 1295

Other funds holding OGN

Merit Financial Group's OGN Position: Q3 2026 in Review

Merit Financial Group sold out of Organon & Co (OGN) in Q3 2026, closing a stake of 10,004 shares — an estimated $135K sold.

Merit Financial Group first reported a position in OGN in Q1 2025 and held it in 5 quarters. The position peaked at $351K in Q3 2025. 311 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Merit Financial Group reported no remaining Organon & Co position as of Q3 2026 after selling out during the quarter.
  • Merit Financial Group sold 10,004 Organon & Co shares in Q3 2026, an estimated $135K.
  • Merit Financial Group first reported a position in Organon & Co in Q1 2025 and held it in 5 quarters.
  • Merit Financial Group's Organon & Co position peaked at $351K in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.